Pär Myrelid (P Myrelid, Par Myrelid)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 28

Top Venues

Alimentary pharmacology & therapeutics

Scandinavian journal of gastroenterology

Journal of Crohn's & colitis

PloS one

Linkopings universitet

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Linkopings universitet

Sweden

MD, PhD :: IKE/Dept of Surgery

Publications

Timothy Raine, Pär Myrelid, Hannah Gordon, Michel Adamina
ECCO Crohn's Disease Guidelines-A Personal View of the Journey from Questions to Recommendations. Journal of Crohn's & colitis (2024)
Timothy Raine, Pär Myrelid, Hannah Gordon, Michel Adamina
ECCO Crohn's Disease Guidelines-A Personal View of the Journey from Questions to Recommendations. Journal of Crohn's & colitis (2024)
Erik Lundqvist, Ida Hed Myrberg, Sol Erika Boman, Deborah Saraste, Caroline E Weibull, Kalle Landerholm, Staffan Haapaniemi, Anna Martling, Pär Myrelid, Caroline Nordenvall
Autoimmune and Metabolic Diseases and the Risk of Early-Onset Colorectal Cancer, a Nationwide Nested Case-Control Study. Cancers 15 (3) (2023)
Karolina Härle, Sussanne Börjeson, Olof Hallböök, Pär Myrelid, Ingela Thylén
Healthcare professionals' experiences of providing care for patients with enterocutaneous fistula in hospital and in homecare: A qualitative study. PloS one 18 (5) (2023)
Karolina Härle, Sussanne Börjeson, Olof Hallböök, Pär Myrelid, Ingela Thylén
Healthcare professionals' experiences of providing care for patients with enterocutaneous fistula in hospital and in homecare: A qualitative study. PloS one 18 (5) (2023)
Erik Lundqvist, Ida Hed Myrberg, Sol Erika Boman, Deborah Saraste, Caroline E Weibull, Kalle Landerholm, Staffan Haapaniemi, Anna Martling, Pär Myrelid, Caroline Nordenvall
Autoimmune and Metabolic Diseases and the Risk of Early-Onset Colorectal Cancer, a Nationwide Nested Case-Control Study. Cancers 15 (3) (2023)
Karolina Härle, Sussanne Börjeson, Olof Hallböök, Pär Myrelid, Ingela Thylén
Healthcare professionals' experiences of providing care for patients with enterocutaneous fistula in hospital and in homecare: A qualitative study. PloS one 18 (5) (2023)
Emma Druvefors, Roland Erik Andersson, Ulf Hammar, Kalle Landerholm, Pär Myrelid
Minor impact on fertility in men with inflammatory bowel disease: A National Cohort Study from Sweden. Alimentary pharmacology & therapeutics 56 (2) (2022)
Maria Chaparro, Lumir Kunovsky, Mariam Aguas, Moran Livne, Pauline Riviere, Ariella Bar-Gil Shitrit, Pär Myrelid, Maite Arroyo, Manuel Barreiro-de Acosta, Michelle Bautista, Livia Biancone, Irit Avni Biron, Trine Boysen, Daniel Carpio, Beatriz Castro, Gabriele Dragoni, Pierre Ellul, Stefan D Holubar, Miguel Ángel de Jorge, Eduardo Leo, Noemí Manceñido, Annick Moens, Tamás Molnár, Patricia Ramírez de la Piscina, Petr Ricanek, Ladislava Sebkova, Laura Sempere, Niels Teich, Javier P Gisbert, Mette Julsgaard
Surgery due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an ECCO Confer Multicentre Case Series [Scar Study]. Journal of Crohn's & colitis 16 (9) (2022)
Michael Eberhardson, Pär Myrelid, Jonas K Söderling, Anders Ekbom, null null, Åsa H Everhov, Charlotte R H Hedin, Martin Neovius, Jonas F Ludvigsson, Ola Olén
Tumour necrosis factor inhibitors in Crohn's disease and the effect on surgery rates. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 24 (4) (2022)
Karolina Härle, Sussanne Börjeson, Olof Hallböök, Pär Myrelid, Ingela Thylèn
Putting life on hold: A longitudinal phenomenological-hermeneutic study of living with [or close to someone with] an enterocutaneous fistula before and after reconstructive surgery. Journal of clinical nursing (2022)
Pär Myrelid, Johan D Söderholm
Editorial: what is normal function of a pelvic pouch? Alimentary pharmacology & therapeutics 55 (11) (2022)
Olga Biskou, Felipe Meira de-Faria, Susanna M Walter, Martin E Winberg, Staffan Haapaniemi, Pär Myrelid, Johan D Söderholm, Åsa V Keita
Increased Numbers of Enteric Glial Cells in the Peyer's Patches and Enhanced Intestinal Permeability by Glial Cell Mediators in Patients with Ileal Crohn's Disease. Cells 11 (3) (2022)
Mohammed Deputy, Guy Henry Thomas Worley, Komal Patel, Jordan A Fletcher, Ailsa Hart, Mattias Block, Tom Øresland, Pär Myrelid, Omar Faiz
Long-term outcome and quality of life after continent ileostomy for ulcerative colitis: A systematic review. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland 23 (9) (2021)
Gabriella Bröms, Jonas Söderling, Michael C Sachs, Jonas Halfvarson, null null, Pär Myrelid, Jonas F Ludvigsson, Åsa H Everhov, Ola Olén
Capturing biologic treatment for IBD in the Swedish Prescribed Drug Register and the Swedish National Patient Register - a validation study. Scandinavian journal of gastroenterology 56 (4) (2021)
Michel Adamina, Roger Feakins, Marietta Iacucci, Antonino Spinelli, Rosanna Cannatelli, André D'Hoore, Ann Driessen, Konstantinos Katsanos, Aart Mookhoek, Pär Myrelid, Gianluca Pellino, Georgios Peros, Gian Eugenio Tontini, Monika Tripathi, Henit Yanai, Magali Svrcek
ECCO Topical Review Optimising Reporting in Surgery, Endoscopy, and Histopathology. Journal of Crohn's & colitis 15 (7) (2021)
Isabella Visuri, Carl Eriksson, Ola Olén, Yang Cao, Emelie Mårdberg, Olof Grip, Anders Gustavsson, Henrik Hjortswang, Pontus Karling, Scott Montgomery, Pär Myrelid, Jonas F Ludvigsson, Jonas Halfvarson
Editorial: infliximab or adalimumab as first- or second-line anti-TNF-conflicting evidence-authors' reply. Alimentary pharmacology & therapeutics 54 (6) (2021)
Anders Forss, Mark Clements, Pär Myrelid, Hans Strid, Charlotte Söderman, Agnieszka Wagner, David Andersson, Fredrik Hjelm, null null, Ola Olén, Jonas F Ludvigsson, Jonas Halfvarson
Prospective observational study on Stelara (ustekinumab) assessing effectiveness in Crohn's disease (PROSE): a 16-week follow-up. Scandinavian journal of gastroenterology 56 (6) (2021)
Isabella Visuri, Carl Eriksson, Ola Olén, Yang Cao, Emelie Mårdberg, Olof Grip, Anders Gustavsson, Henrik Hjortswang, Pontus Karling, Scott Montgomery, Pär Myrelid, null null, Jonas F Ludvigsson, Jonas Halfvarson
Predictors of drug survival: A cohort study comparing anti-tumour necrosis factor agents using the Swedish inflammatory bowel disease quality register. Alimentary pharmacology & therapeutics 54 (7) (2021)
Anders Forss, Mark Clements, David Bergman, Bjorn Roelstraete, Gilaad G Kaplan, Pär Myrelid, Jonas Halfvarson, Ola Olén, Jonas F Ludvigsson
A nationwide cohort study of the incidence of inflammatory bowel disease in Sweden from 1990 to 2014. Alimentary pharmacology & therapeutics 55 (6) (2021)
Åsa H Everhov, Michael C Sachs, Jonas F Ludvigsson, Hamed Khalili, Johan Askling, Martin Neovius, Pär Myrelid, Jonas Halfvarson, Caroline Nordenvall, Jonas Söderling, Ola Olén, null null
Work Loss in Relation to Pharmacological and Surgical Treatment for Crohn's Disease: A Population-Based Cohort Study. Clinical epidemiology 12 (2020)
Sarita Shrestha, Ola Olén, Carl Eriksson, Åsa H Everhov, Pär Myrelid, Isabella Visuri, Jonas F Ludvigsson, Ida Schoultz, Scott Montgomery, Michael C Sachs, Jonas Halfvarson, null null, Malin Olsson, Henrik Hjortswang, Jonas Bengtsson, Hans Strid, Marie Andersson, Susanna Jäghult, Michael Eberhardson, Caroline Nordenvall, Jan Björk, Ulrika L Fagerberg, Martin Rejler, Olof Grip, Pontus Karling, Mattias Block, Eva Angenete, Per M Hellström, Anders Gustavsson
The use of ICD codes to identify IBD subtypes and phenotypes of the Montreal classification in the Swedish National Patient Register. Scandinavian journal of gastroenterology 55 (4) (2020)
Hamed Khalili, Åsa H Everhov, Jonas Halfvarson, Jonas F Ludvigsson, Johan Askling, Pär Myrelid, Jonas Söderling, Ola Olen, Martin Neovius, null null
Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in Sweden. Alimentary pharmacology & therapeutics 52 (4) (2020)
T D Kalman, Å H Everhov, C Nordenvall, M C Sachs, J Halfvarson, A Ekbom, J F Ludvigsson, Pär Myrelid, O Olén
Decrease in primary but not in secondary abdominal surgery for Crohn's disease: nationwide cohort study, 1990-2014. The British journal of surgery 107 (11) (2020)
Jonas F Ludvigsson, Marie Andersson, Jonas Bengtsson, Michael Eberhardson, Ulrika L Fagerberg, Olof Grip, Jonas Halfvarson, Henrik Hjortswang, Susanna Jäghult, Pontus Karling, Caroline Nordenvall, Ola Olén, Malin Olsson, Martin Rejler, Hans Strid, Pär Myrelid
Swedish Inflammatory Bowel Disease Register (SWIBREG) - a nationwide quality register. Scandinavian journal of gastroenterology 54 (9) (2019)
Åsa H Everhov, Michael C Sachs, Petter Malmborg, Caroline Nordenvall, Pär Myrelid, Hamed Khalili, Maria Elmberg, Anders Ekbom, Johan Askling, Gustav Jakobsson, Jonas Halfvarson, Jonas F Ludvigsson, Ola Olén
Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients. Scandinavian journal of gastroenterology 54 (1) (2019)
Magnus Svensson, David Bergman, Ola Olén, Pär Myrelid, Johan Bohr, Anna Wickbom, Hamed Khalili, Andreas Münch, Jonas Halfvarson, Jonas F Ludvigsson
Validating microscopic colitis (MC) in Swedish pathology registers. Scandinavian journal of gastroenterology 53 (12) (2019)
Pär Myrelid
Editorial: post-operative complications in elderly onset inflammatory bowel disease-what is surgery, what is disease, and what is delay of surgery? Alimentary pharmacology & therapeutics 48 (3) (2019)

Pär Myrelid.css-eqlu8i{font-size:small;padding-left:4px;} (P Myrelid, Par Myrelid)

Publication Activity (10 Years)

Top Topics

Top Venues

Pär Myrelid (P Myrelid, Par Myrelid)